Ken Griffin’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-147,323
Closed -$2.91M 15890
2024
Q1
$3.18M Buy
+147,323
New +$3.21M ﹤0.01% 4674
2021
Q2
Sell
-181,473
Closed -$2.96M 15036
2021
Q1
$2.96M Buy
+181,473
New +$2.97M ﹤0.01% 5478

Ken Griffin's LBPH Position: Q2 2024 in Review

Ken Griffin sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q2 2024, closing a stake of 147,323 shares — an estimated $2.91M sold.

Ken Griffin first reported a position in LBPH in Q1 2021 and held it in 2 quarters. The position peaked at $3.18M in Q1 2024. 100 funds tracked by Wall St. Rank hold LBPH as of Q2 2024.

  • Ken Griffin reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Ken Griffin sold 147,323 Longboard Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $2.91M.
  • Ken Griffin first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Ken Griffin's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $3.18M in Q1 2024.
  • 100 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.